Delivery Order SPE2DE24D0013-SPE2D625F1NQT
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular...
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1NQTDelivery Order
The U.S. Defense Logistics Agency (under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $8,820.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing supply of diagnostic equipment and testing solutions to federal healthcare systems, leveraging the company's extensive expertise in molecular diagnostics for infectious diseases and clinical testing. Cepheid maintains significant federal presence through multiple indefinite delivery vehicle contracts with the Veterans Affairs system, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 and a $2.5 million contract with VA's Veterans Integrated Service Network 21, both providing PCR testing reagents and molecular diagnostic systems through 2030. The current delivery order fits within this established framework of providing diagnostic testing capabilities, supporting federal agencies' ongoing needs for rapid molecular diagnostic solutions across infectious disease detection, including COVID-19, influenza, RSV, and other clinical conditions. No subcontractors were identified for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 8/21/25 |